Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Virpax Pharmaceuticals, Inc. - Common Stock
(NQ:
VRPX
)
0.6695
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virpax Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Get insights into the top gainers and losers of Friday's pre-market session.
↗
February 28, 2025
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via
Chartmill
US Stocks Likely To Open Higher Following A Sell-Off, 'This Choppy Start To 2025 Isn't Abnormal. Don't Panic,' Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections
↗
February 28, 2025
U.S. stock futures rose on Friday following Thursday's sell-off. Futures advanced except the small-cap gauge Russell 2000.
Via
Benzinga
These stocks are moving in today's after hours session
↗
February 27, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology
February 27, 2025
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Unusual volume stocks in Tuesday's session
↗
February 18, 2025
Let's have a look at the stocks with an unusual volume in today's session.
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
February 18, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
February 18, 2025
Via
Benzinga
What's going on in today's after hours session
↗
February 14, 2025
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
↗
February 14, 2025
Let's dive into the action on the US markets on Friday. Here are the most active stocks that are driving the market today.
Via
Chartmill
Unusual volume stocks in Friday's session
↗
February 14, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via
Chartmill
Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate
↗
February 14, 2025
Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.
Via
Benzinga
Friday's session: gap up and gap down stocks
↗
February 14, 2025
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
Top movers in Friday's pre-market session
↗
February 14, 2025
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
February 14, 2025
Via
Benzinga
Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
↗
February 14, 2025
Via
Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session.
↗
February 13, 2025
The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study
February 13, 2025
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference
January 31, 2025
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals’ $6 Million Follow-On Offering
January 30, 2025
From
Spartan Capital Securities, LLC
Via
GlobeNewswire
Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants
January 30, 2025
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants
January 28, 2025
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 06, 2024
Via
Benzinga
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
↗
December 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 22, 2024
Via
Benzinga
Why Is Virpax Pharmaceuticals Stock Gaining On Friday?
↗
November 22, 2024
Virpax Pharmaceuticals shares are up 59.4% after announcing an extended collaboration with NCATS to advance its NES100 pain management candidate. Virpax also announced results from a minipig Dose Range...
Via
Benzinga
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
November 22, 2024
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
↗
November 22, 2024
Via
Benzinga
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
November 21, 2024
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
